Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited acquired 2,173 shares of Rani Therapeutics stock in a transaction dated Friday, April 28th. The shares were bought at an average cost of $4.71 per share, with a total value of $10,234.83. Following the transaction, the insider now owns 6,854,674 shares […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited purchased 1,901 shares of the company’s stock in a transaction on Friday, April 14th. The shares were purchased at an average cost of $5.27 per share, with a total value of $10,018.27. Following the purchase, the insider now owns 6,835,998 shares […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited bought 3,577 shares of Rani Therapeutics stock in a transaction that occurred on Wednesday, April 12th. The stock was purchased at an average cost of $5.48 per share, for a total transaction of $19,601.96. Following the purchase, the insider now owns […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited acquired 3,587 shares of the company’s stock in a transaction on Monday, April 3rd. The stock was bought at an average cost of $5.23 per share, with a total value of $18,760.01. Following the completion of the acquisition, the insider now […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited purchased 12,230 shares of Rani Therapeutics stock in a transaction that occurred on Thursday, March 30th. The stock was purchased at an average price of $4.79 per share, with a total value of $58,581.70. Following the completion of the purchase, the […]